European Journal of Cancer
Volume 38, Supplement 2 , Pages 15-20, February 2002

Capecitabine as first-line treatment in colorectal cancer:

pooled data from two large, phase III trials

  • C Twelves

      Affiliations

    • Corresponding Author InformationTel.: +44-141-211-1712; fax: +44-141-211-1869
    • ,
  • on behalf of the Xeloda Colorectal Cancer Group

Alexander Stone Building, CRC Department of Medical Oncology, Switchback Road, Garscube Estate, Bearsden, Glasgow G61 1BD, UK

Received 25 June 2001; received in revised form 26 November 2001; accepted 29 November 2001.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(01)00415-4

European Journal of Cancer
Volume 38, Supplement 2 , Pages 15-20, February 2002

Article Tools

* Image Usage & Resolution